The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors

A Spannhoff, AT Hauser, R Heinke… - ChemMedChem …, 2009 - Wiley Online Library
Epigenetics is defined as heritable changes to the transcriptome that are independent of
changes in the genome. The biochemical modifications that govern epigenetics are DNA …

The role of genetic markers in the management of prostate cancer

AD Choudhury, R Eeles, SJ Freedland, WB Isaacs… - European urology, 2012 - Elsevier
CONTEXT: Despite widespread screening for prostate cancer (PCa) and major advances in
the treatment of metastatic disease, PCa remains the second most common cause of cancer …

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis

JM Lincecum, FG Vieira, MZ Wang, K Thompson… - Nature …, 2010 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse …

[HTML][HTML] Microarray data quality control improves the detection of differentially expressed genes

A Kauffmann, W Huber - Genomics, 2010 - Elsevier
Microarrays have become a routine tool for biomedical research. Data quality assessment is
an essential part of the analysis, but it is still not easy to perform objectively or in an …

miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer

OF Karatas, E Guzel, I Suer, ID Ekici, T Caskurlu… - PloS one, 2014 - journals.plos.org
Prostate cancer (PCa) is currently the most frequently diagnosed malignancy in the western
countries. It is more prevalent in older men with 75% of the incident cases above 65 years …

MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer

KRM Leite, A Tomiyama, ST Reis… - The Journal of …, 2011 - Elsevier
PURPOSE:: Abnormal miRNA expression has emerged as crucial factors in carcinogenesis
and is important in the comprehension of prostate cancer behavior. We determined the …

Cancer treatment of the future: inhibitors of histone methyltransferases

A Spannhoff, W Sippl, M Jung - The international journal of biochemistry & …, 2009 - Elsevier
Cancer in humans is the result of a multi-step process. This process often involves the
activation of oncogenes and/or the inactivation of tumor suppressor genes. These two steps …

Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer

NC Pressinotti, H Klocker, G Schäfer, VD Luu… - Molecular cancer, 2009 - Springer
Background Despite recent progress in the identification of genetic and molecular
alterations in prostate cancer, markers associated with tumor progression are scarce …

MicroRNAs as prognostic markers in prostate cancer

I Suer, E Guzel, OF Karatas, CJ Creighton… - The …, 2019 - Wiley Online Library
Background Prostate cancer (PCa) is the most commonly diagnosed malignancy in men
who are especially over the age of 50 years in the western countries. Currently used …

Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma

HS Bachmann, LC Heukamp… - … journal of cancer, 2011 - Wiley Online Library
Molecular markers predictive of prostate cancer prognosis are urgently needed.
Overexpression of the antiapoptotic protein, Bcl‐2, has repeatedly been shown to be …